Expand RLMD Menu
RLMD MENU

RLMD Stock Posts


$RLMD Earnings May 12 AMC. 15-May-26 Straddle Implies ±6.9% Move vs 6qtr Absolute Avg 1.7%
Upcoming Earnings

RLMD Relmada Therapeutics7.13-0.23 (-3.1%)

Relmada Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±8.5% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±2.3%. View Expected Move (Conf Call: May 12 4:30 PM)
Upcoming Earnings

RLMD Relmada Therapeutics6.15-0.06 (-1.0%)

Relmada Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±7.8% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.7%. View Expected Move (Conf Call: Mar 19 4:30 PM)
Unusual Option Volume

RLMD Relmada Therapeutics6.70-0.47 (-6.6%)

Relmada Therapeutics trades 2,617 contracts. The company has the following event: Leerink Partners Global Healthcare Conference on Mar 10, 2026. News: Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference
View Details...
RLMD #RelmadaTherapeutics stock declines -1.9% in after hours trading. See the latest news.

After Hours Decliner

RLMD Relmada Therapeutics7.01+2.56+57.5%

After Hours:6.88-0.13 (-1.9%)

Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference

Globe NewswireMon, 9-Mar 4:30 PM
Unusual Option Volume

RLMD Relmada Therapeutics6.02+1.57 (+35.3%)

Relmada Therapeutics trades 2,269 contracts. The company has the following event: 12-Month Phase 2 Interim Data Presentation for NDV-01 in Non-Muscle Invasive Bladder Cancer on Mar 9, 2026. News: Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes